UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Worth Asset Management LLC

Worth Asset Management LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 873 shares of the healthcare conglomerate’s stock after selling 535 shares during the quarter. Worth Asset Management LLC’s holdings in UnitedHealth Group were worth $442,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group during the third quarter worth about $27,000. Global Wealth Strategies & Associates grew its position in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares in the last quarter. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $32,000. Quarry LP increased its stake in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the last quarter. Finally, VitalStone Financial LLC boosted its holdings in shares of UnitedHealth Group by 600.0% in the 2nd quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 60 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.0 %

Shares of NYSE:UNH traded up $5.17 during midday trading on Wednesday, reaching $519.42. The company had a trading volume of 1,400,908 shares, compared to its average volume of 3,382,798. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market cap of $478.01 billion, a price-to-earnings ratio of 33.84, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a fifty day simple moving average of $557.79 and a two-hundred day simple moving average of $561.72.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the company posted $6.56 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

Analysts Set New Price Targets

Several research firms have recently commented on UNH. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $627.58.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.